radium-223

December 7, 2017

Safety Concerns Make Bayer Unblind Prostate Cancer Trial of Xofigo Combination

News

An Independent Data Monitoring Committee has asked Bayer to unblind a Phase 3 clinical trial of a Xofigo (radium-223)-based therapy for prostate cancer after data indicated more bone fractures in ... Read more

September 6, 2016

Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy

News

The U.K.’s National Institute for Clinical Excellence (NICE) has approved radium-223 to treat prostate cancer that has spread to the bones for routine National Health Service (NHS) use. The approval comes in the ... Read more

March 10, 2016March 10, 2016

New Advanced Prostate Cancer Treatment Approach, Combining Radiotherapies, Being Tested in Belfast

News

Queen’s University Belfast researchers, in partnership with the Belfast Trust, are leading a clinical trial evaluating a new combination of two radiotherapy treatments in men with advanced prostate cancer (PC), where the cancer ... Read more

October 28, 2014October 28, 2014

Study Finds Radium-223 Effective in Prostate Cancer Treatment Independently of Docetaxel Use

News

A recent study titled “Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis ... Read more

September 12, 2014September 12, 2014

New Guidelines to Treat Advanced Prostate Cancer

News

The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) have published a joint clinical practice guideline on treating men with metastatic castration-resistant prostate cancer (CRPC). The study ... Read more